DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Zaprinast
Zaprinast
Effects of Phosphodiesterase Inhibitors on Human Lung Mast Cell and Basophil Function
Chapter Introduction
Inhibitors of Cyclic-GMP Phosphodiesterase Alter Excitation of Limulus Ventral Photoreceptors in Ca2+-Dependent Fashion
Repurposing Erectile Dysfunction Drugs Tadalafil and Vardenafil to Increase Bone Mass
Phosphodiesterase (PDE)
Rolipram, but Not Siguazodan Or Zaprinast, Inhibits the Excitatory Noncholinergic Neurotransmission in Guinea-Pig Bronchi
Integrated Technologies for the Characterization Of
Effects of Various Selective Phosphodiesterase Inhibitors on Relaxation and Cyclic Nucleotide Contents in Porcine Iris Sphincter
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Download Product Insert (PDF)
Phosphodiesterase Inhibitors in Acute Lung Injury: What Are the Perspectives?
Celltransmissions Newsletter
Elevated Intracellular Camp Concentration Mediates Growth Suppression in Glioma Cells
Phosphodiesterase 11: a Brief Review of Structure, Expression and Function
Effects of the Speci®C Phosphodiesterase Inhibitors on Alloxan-Induced Diabetic Rabbit Cavernous Tissue in Vitro
Characterization of the First Potent and Selective PDE9 Inhibitor Using A
Analgesia Additive Interaction Between Tadalafil and Morphine in Experimental Animal Model
Top View
British Journal of Nutrition (2014), 112, 1427–1437 Doi:10.1017/S0007114514002232 Q the Authors 2014
Roflumilast Ameliorates Cognitive Impairment in APP/PS1 Mice Via Camp/CREB/BDNF Signaling and Anti-Neuroinflammatory Effects
Modulation of High Affinity ATP-Dependent Cyclic Nucleotide
Pharmaabkommen A1 E
Rhobtb1 Protects Against Hypertension and Arterial Stiffness by Restraining Phosphodiesterase 5 Activity
New Drugs Review Thorax: First Published As 10.1136/Thx.46.7.512 on 1 July 1991
Customs Tariff - Schedule Xxi - 1
PDE5 Inhibitors Beyond Erectile Dysfunction
Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases
A Full Cycle Anti-Viral Drug Screen Identifies a Clinical Compound
BAY 41-2272 Attenuates CTGF Expression Via Sgc/Cgmp-Independent Pathway in Tgfβ1-Activated Hepatic Stellate Cells
Phenotypic, Chemical and Functional Characterization of Cyclic Nucleotide Phosphodiesterase 4 (PDE4) As a Potential Anthelmintic Drug Target
(51) International Patent Classification: (74) Agent: HARRIS, Bob Et Al.; Viksnins Flarris Padys Malen A61K 31/4725 (2006.01) A6
The Phosphodiesterase 5 Inhibitor Tadalafil Regulates Lipidic
Epimedium Icariin
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Zaprinast, a Well-Known Cyclic Guanosine Monophosphate-Specific
Inhibitors Phosphodiesterase (PDE)
Effects of Rolipram on U46619-Induced Contraction and Cyclic Nucleotide Content in the Porcine Coronary Artery
PDE3 Inhibitors Repurposed As Treatments for Age-Related Cognitive Impairment
Comparative Relaxant Effects of Ataciguat and Zaprinast on Sheep Sphincter of Oddi
Overview of Commonly Used Chinese Herbs
Harmonized Tariff Schedule of the United States (2006) (Rev
WO 2017/033032 Al 2 March 2017 (02.03.2017) P O P C T
Book of Abstracts 2016
Current Concepts on the Reno-Protective Effects of Phosphodiesterase 5 Inhibitors in Acute Kidney Injury: Systematic Search and Review
Known Bioactive Library: LOPAC 1
United States Court of Appeals for the Federal Circuit ______